Loss of tau results in defects in photoreceptor development and progressive neuronal degeneration in Drosophila

Developmental Neurobiology

Volumn 74, Issue 12, 2014, Pages 1210-1225

  Bolkan, Bonnie J ^a   Kretzschmar, Doris ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Drosophila; Eye development; Neurodegeneration; Tau

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 4; TAU PROTEIN; DROSOPHILA PROTEIN; ISOPROTEIN; MAPT PROTEIN, HUMAN; TAU PROTEIN, DROSOPHILA;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DROSOPHILA; EYE; IN VIVO STUDY; MOUSE; MUTATION; NERVE CELL; NERVE CELL DEGENERATION; NONHUMAN; PHENOTYPE; PHOTORECEPTOR; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROGRESSIVE NEURONAL DEGENERATION; PROTEIN EXPRESSION; WILD TYPE; ALTERNATIVE RNA SPLICING; ANIMAL; DEFICIENCY; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MICROTUBULE; NERVE DEGENERATION; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DEGENERATION; TRANSGENIC ANIMAL; ULTRASTRUCTURE;

ALTERNATIVE SPLICING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AXONS; BRAIN; DROSOPHILA; DROSOPHILA PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROTUBULES; MUTATION; NERVE DEGENERATION; PHOTORECEPTOR CELLS, INVERTEBRATE; PROTEIN ISOFORMS; RETINAL DEGENERATION; TAU PROTEINS;

EID: 84937558461     PISSN: 19328451     EISSN: 1932846X     Source Type: Journal    
DOI: 10.1002/dneu.22199     Document Type: Article

References (49)

1. Barten DM, Fanara P, Andorfer C, Hoque N, Wong PY, Husted KH, Cadelina GW, et al. 2012. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J Neurosci 32:7137-7145.
2. Bettencourt da Cruz A, Schwarzel M, Schulze S, Niyyati M, Heisenberg M, Kretzschmar D. 2005. Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila. Mol Biol Cell 16:2433-2442.
3. Bolkan BJ, Triphan T, Kretzschmar D. 2012. Beta-secretase cleavage of the fly amyloid precursor protein is required for glial survival. J Neurosci 32:16181-16192.
4. Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D. 2009. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol Dis 33:274-281.
5. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, et al. 2003. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 162:1623-1627.
6. Chatterjee S, Sang TK, Lawless GM, Jackson GR. 2009. Dissociation of tau toxicity and phosphorylation: Role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum Mol Genet 18:164-177.
7. Chau KW, Chan WY, Shaw PC, Chan HY. 2006. Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila. Biochem Biophys Res Commun 346:150-159.
8. Chen G, League GP, Nam SC. 2010. Role of spastin in apical domain control along the rhabdomere elongation in Drosophila photoreceptor. PLoS One 5:e9480.
9. Choi MC, Raviv U, Miller HP, Gaylord MR, Kiris E, Ventimiglia D, Needleman DJ, et al. 2009. Human microtubule-associated-protein tau regulates the number of protofilaments in microtubules: A synchrotron x-ray scattering study. Biophys J 97:519-527.
10. Combs B, Gamblin TC. 2012. FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions. Biochemistry 51:8597-8607.
11. Couchie D, Charriere-Bertrand C, Nunez J. 1988. Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J Neurochem 50:1894-1899.
12. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. 2001. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179-1187.
13. Dehmelt L, Halpain S. 2005. The MAP2/Tau family of microtubule-associated proteins. Genome Biol 6:204.
14. DiTella MC, Feiguin F, Carri N, Kosik KS, Caceres A. 1996. MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth. J Cell Sci 109 (Pt 2):467-477.
15. Doerflinger H, Benton R, Shulman JM, St Johnston D. 2003. The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium. Development 130:3965-3975.
16. Feuillette S, Miguel L, Frebourg T, Campion D, Lecourtois M. 2010. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. J Neurochem 113:895-903.
17. Friedhoff P, von Bergen M, Mandelkow EM, Davies P, Mandelkow E. 1998. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci USA 95:15712-15717.
18. Gordon-Weeks PR. 1991. Growth cones: the mechanism of neurite advance. Bioessays 13:235-239.
19. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. 1986. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084-6089.
20. Hama H, Kurokawa H, Kawano H, Ando R, Shimogori T, Noda H, Fukami K, Sakaue-Sawano A, Miyawaki A 2011. Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat Neurosci 14:1481-1488.
21. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, et al. 1994. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369:488-491.
22. Heidary G, Fortini ME. 2001. Identification and characterization of the Drosophila tau homolog. Mech Dev 108:171-178.
23. Hummel T, Krukkert K, Roos J, Davis G, Klambt C. 2000. Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron 26:357-370.
24. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. 2009. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53-69.
25. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH. 2002. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34:509-519.
26. Ke YD, Suchowerska AK, van der Hoven J, De Silva DM, Wu CW, van Eersel J, Ittner A, et al. 2012. Lessons from tau-deficient mice. Int J Alzheimers Dis 2012:873270.
27. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. 2006. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 16:230-241.
28. Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. 1997. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci 17:7425-7432.
29. Krishnan N, Kretzschmar D, Rakshit K, Chow E, Giebultowicz JM. 2009. The circadian clock gene period extends healthspan in aging Drosophila melanogaster. Aging (Albany NY) 1:937-948.
30. League GP, Nam SC. 2011. Role of kinesin heavy chain in Crumbs localization along the rhabdomere elongation in Drosophila photoreceptor. PLoS One 6:e21218.
31. LeBoeuf AC, Levy SF, Gaylord M, Bhattacharya A, Singh AK, Jordan MA, Wilson L, et al. 2008. FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action. J Biol Chem 283:36406-36415.
32. Lee VM, Goedert M, Trojanowski JQ. 2001. Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159.
33. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, et al. 2012. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18:291-295.
34. Leonard DS, Bowman VD, Ready DF, Pak WL. 1992. Degeneration of photoreceptors in rhodopsin mutants of Drosophila. J Neurobiol 23:605-626.
35. Li B, Chohan MO, Grundke-Iqbal I, Iqbal K. 2007. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113:501-511.
36. Liu D, Fischer I. 1996. Isolation and sequencing of the 5' end of the rat microtubule-associated protein (MAP1B)-encoding cDNA. Gene 171:307-308.
37. Matus A. 1990. Microtubule-associated proteins and the determination of neuronal form. J Physiol (Paris) 84:134-137.
38. Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, Squire A, Mears A, et al. 2004. GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9:522-530.
39. Ohler U. 2006. Identification of core promoter modules in Drosophila and their application in accurate transcription start site prediction. Nucleic Acids Res 34:5943-5950.
40. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
41. Reinke R, Krantz DE, Yen D, Zipursky SL. 1988. Chaoptin, a cell surface glycoprotein required for Drosophila photoreceptor cell morphogenesis, contains a repeat motif found in yeast and human. Cell 52:291-301.
42. Takei Y, Teng J, Harada A, Hirokawa N. 2000. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol 150:989-1000.
43. Tucker RP. 1990. The roles of microtubule-associated proteins in brain morphogenesis: A review. Brain Res Brain Res Rev 15:101-120.
44. van Swieten J, Spillantini MG. 2007. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17:63-73.
45. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. 1975. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858-1862.
46. Williams DW, Tyrer M, Shepherd D. 2000. Tau and tau reporters disrupt central projections of sensory neurons in Drosophila. J Comp Neurol 428:630-640.
47. Witman GB, Cleveland DW, Weingarten MD, Kirschner MW. 1976. Tubulin requires tau for growth onto microtubule initiating sites. Proc Natl Acad Sci USA 73:4070-4074.
48. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. 2001. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293:711-714.
49. Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM, et al. 2012. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32:3601-3611.